Skip to main content
Pharmaceuticals logoLink to Pharmaceuticals
editorial
. 2015 Jun 5;8(2):277–278. doi: 10.3390/ph8020277

Pharmaceuticals Best Paper Award 2015

Jean Jacques Vanden Eynde 1
PMCID: PMC4491661  PMID: 26110322

It is always a difficult task for a jury to classify articles from a selection of outstanding manuscripts. This was the case again this year when we had to award a prize to three contributions only, whereas we read so many interesting and exciting results published in 2012 and 2013. Anyway, the members of the jury did their job and have the pleasure to announce that the three following publications won the Pharmaceuticals Best Paper Award for 2015.

  • 1st Prize

    Ivana Cacciatore, Erika Fornasari, Leonardo Baldassarre, Catia Cornacchia, Stefania Fulle, Ester Sara Di Filippo, Tiziana Pietrangelo and Francesco Pinnen

    A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells

    Pharmaceuticals 2013, 6(1), 54-69; doi:10.3390/ph6010054

    Available online: http://www.mdpi.com/1424-8247/6/1/54

  • 2nd Prize

    Albert J. Chang, Ravindra DeSilva, Sandeep Jain, Kimberley Lears, Buck Rogers and Suzanne Lapi

    89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors

    Pharmaceuticals 2012, 5(1), 79-93; doi:10.3390/ph5010079

    Available online: http://www.mdpi.com/1424-8247/5/1/79

  • 3rd Prize

    Luiza I. Hernandez, Katie S. Flenker, Frank J. Hernandez, Aloysius J. Klingelhutz, James O. McNamara and Paloma H. Giangrande

    Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers

    Pharmaceuticals 2013, 6(3), 295-319; doi:10.3390/ph6030295

    Available online: http://www.mdpi.com/1424-8247/6/3/295

The Prize Awarding Committee describes the article “A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells” as “An interesting preclinical approach, newly combining antioxidant/metal-chealting (in neuroprotective) molecules for the treatment of neurodegenerative diseases, such as PD or AD”.

We believe these three papers represent valuable contributions to Pharmaceuticals and the scientific literature. On behalf of the Prize Awarding Committee and the Editorial Board of Pharmaceuticals, we warmly congratulate these three groups. In recognition of their accomplishment, Dr. Ivana Cacciatore, Dr. Suzanne Lapi, and Dr. Paloma H. Giangrande will have the opportunity of publishing an additional Open Access format review or research paper, free of charge, in our Journal, Pharmaceuticals.

Prize Awarding Committee

  • Editor-in-Chief

    Dr. Jean Jacques Vanden Eynde

    Laboratory of Organic Chemistry (FS), University of Mons-UMONS, Place du parc, 23, 7000 Mons, Belgium

    E-Mail: jean-jacques.vandeneynde@ex.umons.ac.be

  • Associate Editor

    Dr. Annie Mayence

    Formerly Professor at the Haute Ecole Provinciale de Hainaut-Condorcet, 7330 Saint-Ghislain, Belgium

    E-Mail: annie.mayence@condorcet.be

  • Editorial Board Member

    Prof. Dr. Klaus Kopka Division of Radiopharmaceutical Chemistry, Research Program Imaging and Radiooncology, German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

    E-Mail: k.kopka@dkfz-heidelberg.de

  • Editorial Board Member

    Prof. Dr. Thomas Rades Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 København Ø, Denmark

    E-Mail: thomas.rades@sund.ku.dk


Articles from Pharmaceuticals are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES